Showing results (81-90 of 190) with videos related to

Sort By:
Pageof 19
Sexually Transmitted Diseases|April 1, 1989
Single dose enoxacin for the treatment of uncomplicated urogenital gonorrheaL M Albrecht, M J Rybak, H H Schubiner, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1995
Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection modelS M Palmer, S L Kang, D M Cappelletty, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1992
In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycinK C Lamp, M J Rybak, E M Bailey, et al.
DICP : the Annals of Pharmacotherapy|July 1, 1990
Coagulase-negative staphylococci: incidence, pathogenicity, and treatment in the 1990sE M Bailey, T D Constance, L M Albrecht, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1990
Nephrotoxicity of vancomycin, alone and with an aminoglycosideM J Rybak, L M Albrecht, S C Boike, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1986
Clinical use and toxicity of high-dose tobramycin in patients with pseudomonal endocarditisM J Rybak, S C Boike, D P Levine, et al.
Clinical Pharmacy|May 1, 1985
Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosageG R Matzke, J M Kovarik, M J Rybak, et al.
Infection and Immunity|July 19, 2000
Influence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditisR C Mercier, M J Rybak, A S Bayer, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1996
Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infectionsA S Benko, D M Cappelletty, J A Kruse, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1987
Alanine aminopeptidase and beta 2-microglobulin excretion in patients receiving vancomycin and gentamicinM J Rybak, J J Frankowski, D J Edwards, et al.
Pageof 19